SIRT1 is also upregulated in hepatocellular carcinomas (HCCs), where it increases cancer cells’ invasiveness and metastatic potential through the activation of SNAIL, TWIST, and VIMENTIN, and decreases the expression of E-cadherin [109,207]. Here, VIM is linked to hepatocellular carcinoma.